| protein hydroxylation | GO:0018126 | 4 | 0.427 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.380 | |
| extracellular structure organization | GO:0043062 | 148 | 0.299 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.221 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.213 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.203 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.202 | |
| peptidyl proline hydroxylation | GO:0019511 | 3 | 0.181 | |
| response to amino acid | GO:0043200 | 37 | 0.162 | |
| oxidation reduction process | GO:0055114 | 342 | 0.148 | |
| angiogenesis | GO:0001525 | 201 | 0.147 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.130 | |
| regulation of cell motility | GO:2000145 | 236 | 0.128 | |
| skeletal system development | GO:0001501 | 356 | 0.125 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.124 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.109 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.106 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.103 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.103 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.097 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.096 | |
| cell adhesion | GO:0007155 | 329 | 0.088 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.082 | |
| connective tissue development | GO:0061448 | 179 | 0.080 | |
| regulation of cell migration | GO:0030334 | 219 | 0.078 | |
| forebrain development | GO:0030900 | 302 | 0.076 | |
| response to acid chemical | GO:0001101 | 111 | 0.076 | |
| ossification | GO:0001503 | 216 | 0.075 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.074 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.074 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.071 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.068 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.067 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.067 | |
| muscle tissue development | GO:0060537 | 308 | 0.067 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.067 | |
| cartilage development | GO:0051216 | 140 | 0.066 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.064 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.062 | |
| collagen fibril organization | GO:0030199 | 32 | 0.060 | |
| male gamete generation | GO:0048232 | 285 | 0.057 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.057 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.056 | |
| bone development | GO:0060348 | 120 | 0.056 | |
| spermatogenesis | GO:0007283 | 284 | 0.052 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.052 | |
| regulation of secretion | GO:0051046 | 274 | 0.052 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.051 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.050 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.048 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.048 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.048 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.048 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.046 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.046 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.046 | |
| chemotaxis | GO:0006935 | 247 | 0.045 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.044 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.044 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.044 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.043 | |
| synaptic transmission | GO:0007268 | 329 | 0.042 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.042 | |
| regulation of protein localization | GO:0032880 | 231 | 0.042 | |
| amine metabolic process | GO:0009308 | 45 | 0.041 | |
| ear development | GO:0043583 | 200 | 0.041 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.040 | |
| defense response to other organism | GO:0098542 | 197 | 0.040 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.040 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.039 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.039 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.038 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.038 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.038 | |
| synapse organization | GO:0050808 | 125 | 0.037 | |
| digestive tract development | GO:0048565 | 190 | 0.037 | |
| axonogenesis | GO:0007409 | 274 | 0.037 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.036 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.036 | |
| regulation of ossification | GO:0030278 | 112 | 0.036 | |
| response to inorganic substance | GO:0010035 | 96 | 0.036 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.036 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.036 | |
| limb morphogenesis | GO:0035108 | 149 | 0.035 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.035 | |
| regionalization | GO:0003002 | 337 | 0.035 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.034 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.034 | |
| cell cell adhesion | GO:0098609 | 41 | 0.034 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.034 | |
| oligosaccharide biosynthetic process | GO:0009312 | 7 | 0.033 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.033 | |
| palate development | GO:0060021 | 76 | 0.033 | |
| response to oxygen levels | GO:0070482 | 62 | 0.032 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.032 | |
| digestive system development | GO:0055123 | 200 | 0.032 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.032 | |
| peptidyl proline modification | GO:0018208 | 6 | 0.032 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.031 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.031 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.031 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.031 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.031 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.030 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.030 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.030 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.030 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.030 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.029 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.028 | |
| sensory perception of sound | GO:0007605 | 97 | 0.028 | |
| sensory perception | GO:0007600 | 245 | 0.028 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.027 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.027 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.027 | |
| respiratory tube development | GO:0030323 | 167 | 0.027 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.027 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.027 | |
| inflammatory response | GO:0006954 | 244 | 0.027 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.026 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.026 | |
| camera type eye development | GO:0043010 | 266 | 0.026 | |
| response to oxidative stress | GO:0006979 | 123 | 0.026 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.026 | |
| biomineral tissue development | GO:0031214 | 64 | 0.026 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.025 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.025 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.025 | |
| anion transport | GO:0006820 | 177 | 0.025 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.025 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.025 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.025 | |
| regulation of protein transport | GO:0051223 | 163 | 0.025 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.025 | |
| tissue homeostasis | GO:0001894 | 115 | 0.025 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.025 | |
| developmental maturation | GO:0021700 | 193 | 0.025 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.024 | |
| wound healing | GO:0042060 | 157 | 0.024 | |
| detection of stimulus | GO:0051606 | 84 | 0.024 | |
| gastrulation | GO:0007369 | 116 | 0.024 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.024 | |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.024 | |
| muscle cell development | GO:0055001 | 133 | 0.024 | |
| dna metabolic process | GO:0006259 | 303 | 0.023 | |
| skin development | GO:0043588 | 220 | 0.023 | |
| cellular response to lipid | GO:0071396 | 145 | 0.023 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.023 | |
| negative regulation of cell substrate adhesion | GO:0010812 | 16 | 0.023 | |
| gland development | GO:0048732 | 330 | 0.023 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.023 | |
| defense response to virus | GO:0051607 | 68 | 0.023 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.023 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.023 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.022 | |
| heart morphogenesis | GO:0003007 | 178 | 0.022 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.022 | |
| organelle assembly | GO:0070925 | 177 | 0.022 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.021 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.021 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.021 | |
| protein heterooligomerization | GO:0051291 | 14 | 0.021 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.021 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.021 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.021 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.021 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.021 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.020 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.020 | |
| protein catabolic process | GO:0030163 | 221 | 0.020 | |
| leukocyte migration | GO:0050900 | 124 | 0.020 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.020 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.020 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.020 | |
| regulation of system process | GO:0044057 | 200 | 0.020 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.020 | |
| head morphogenesis | GO:0060323 | 34 | 0.020 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.020 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.020 | |
| endothelium development | GO:0003158 | 45 | 0.019 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.019 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.019 | |
| negative regulation of macrophage chemotaxis | GO:0010760 | 1 | 0.019 | |
| fat cell differentiation | GO:0045444 | 160 | 0.019 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.019 | |
| endocytosis | GO:0006897 | 168 | 0.019 | |
| stem cell development | GO:0048864 | 219 | 0.019 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.019 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| cell maturation | GO:0048469 | 127 | 0.018 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.018 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.018 | |
| peptide metabolic process | GO:0006518 | 46 | 0.018 | |
| protein oligomerization | GO:0051259 | 67 | 0.018 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.018 | |
| cell recognition | GO:0008037 | 83 | 0.018 | |
| epidermis development | GO:0008544 | 187 | 0.018 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.018 | |
| neuron migration | GO:0001764 | 122 | 0.018 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.018 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.018 | |
| response to growth factor | GO:0070848 | 198 | 0.018 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.018 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.017 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.017 | |
| immune effector process | GO:0002252 | 321 | 0.017 | |
| respiratory system development | GO:0060541 | 190 | 0.017 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.017 | |
| lipid localization | GO:0010876 | 126 | 0.017 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.017 | |
| response to metal ion | GO:0010038 | 47 | 0.017 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.017 | |
| gtp catabolic process | GO:0006184 | 143 | 0.017 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.017 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.017 | |
| protein maturation | GO:0051604 | 176 | 0.017 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.016 | |
| protein processing | GO:0016485 | 163 | 0.016 | |
| chondrocyte development | GO:0002063 | 24 | 0.016 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.016 | |
| organelle localization | GO:0051640 | 179 | 0.016 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.016 | |
| cytokine production | GO:0001816 | 319 | 0.016 | |
| regulation of defense response | GO:0031347 | 233 | 0.016 | |
| organic acid transport | GO:0015849 | 101 | 0.016 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.016 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.016 | |
| intracellular protein transport | GO:0006886 | 204 | 0.016 | |
| chromatin organization | GO:0006325 | 206 | 0.015 | |
| circulatory system process | GO:0003013 | 197 | 0.015 | |
| fibrinolysis | GO:0042730 | 3 | 0.015 | |
| insulin processing | GO:0030070 | 2 | 0.015 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.015 | |
| innate immune response | GO:0045087 | 157 | 0.015 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.015 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.015 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.015 | |
| face development | GO:0060324 | 38 | 0.015 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.015 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.015 | |
| endomembrane system organization | GO:0010256 | 147 | 0.015 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.015 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.015 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.015 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.015 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.015 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.015 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.015 | |
| cell growth | GO:0016049 | 130 | 0.015 | |
| positive regulation of neuron projection regeneration | GO:0070572 | 2 | 0.015 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.015 | |
| transmembrane transport | GO:0055085 | 412 | 0.015 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.014 | |
| recognition of apoptotic cell | GO:0043654 | 3 | 0.014 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.014 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.014 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.014 | |
| oocyte axis specification | GO:0007309 | 2 | 0.014 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.014 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.014 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.014 | |
| detection of molecule of bacterial origin | GO:0032490 | 2 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| synapse assembly | GO:0007416 | 56 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.014 | |
| cerebral cortex development | GO:0021987 | 86 | 0.014 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.014 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.014 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.014 | |
| ear morphogenesis | GO:0042471 | 118 | 0.014 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.013 | |
| muscle adaptation | GO:0043500 | 39 | 0.013 | |
| stem cell differentiation | GO:0048863 | 268 | 0.013 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.013 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.013 | |
| bone mineralization | GO:0030282 | 54 | 0.013 | |
| response to hypoxia | GO:0001666 | 58 | 0.013 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.013 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.013 | |
| learning or memory | GO:0007611 | 148 | 0.013 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.013 | |
| myosin filament assembly | GO:0031034 | 2 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.013 | |
| blood circulation | GO:0008015 | 195 | 0.013 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.013 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.013 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.013 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.013 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.013 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.013 | |
| rhythmic process | GO:0048511 | 174 | 0.013 | |
| face morphogenesis | GO:0060325 | 29 | 0.013 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.013 | |
| replacement ossification | GO:0036075 | 26 | 0.013 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.013 | |
| cell junction assembly | GO:0034329 | 52 | 0.013 | |
| phagocytosis | GO:0006909 | 66 | 0.012 | |
| vesicle localization | GO:0051648 | 86 | 0.012 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.012 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.012 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.012 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.012 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.012 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.012 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.012 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.012 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.012 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.012 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.012 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.012 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.012 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.012 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.012 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.012 | |
| neuron projection guidance | GO:0097485 | 141 | 0.012 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.012 | |
| protein heterotrimerization | GO:0070208 | 8 | 0.012 | |
| wound healing spreading of cells | GO:0044319 | 8 | 0.012 | |
| axon guidance | GO:0007411 | 141 | 0.012 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.012 | |
| organic anion transport | GO:0015711 | 137 | 0.012 | |
| membrane organization | GO:0061024 | 245 | 0.012 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.012 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.011 | |
| mesenchyme development | GO:0060485 | 152 | 0.011 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.011 | |
| placenta development | GO:0001890 | 140 | 0.011 | |
| tissue remodeling | GO:0048771 | 102 | 0.011 | |
| cell junction organization | GO:0034330 | 77 | 0.011 | |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.011 | |
| response to bmp | GO:0071772 | 14 | 0.011 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.011 | |
| germ cell development | GO:0007281 | 185 | 0.011 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.011 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.011 | |
| exocytosis | GO:0006887 | 121 | 0.011 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.011 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.011 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.011 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.011 | |
| response to insulin | GO:0032868 | 100 | 0.011 | |
| regulation of neuron migration | GO:2001222 | 22 | 0.011 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.011 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.011 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.011 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.011 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.011 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.011 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.011 | |
| cardiac chamber development | GO:0003205 | 108 | 0.011 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.011 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.011 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.011 | |
| regulation of synapse assembly | GO:0051963 | 29 | 0.011 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.011 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.011 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.011 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.011 | |
| striated muscle cell development | GO:0055002 | 125 | 0.011 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.011 | |
| cognition | GO:0050890 | 149 | 0.011 | |
| limb development | GO:0060173 | 166 | 0.011 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.011 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.011 | |
| fibril organization | GO:0097435 | 2 | 0.011 | |
| circadian temperature homeostasis | GO:0060086 | 2 | 0.011 | |
| regulation of ion transport | GO:0043269 | 215 | 0.011 | |
| peptide transport | GO:0015833 | 133 | 0.011 | |
| negative regulation of interleukin 10 secretion | GO:2001180 | 2 | 0.011 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.010 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.010 | |
| gtp metabolic process | GO:0046039 | 144 | 0.010 | |
| nucleotide sugar metabolic process | GO:0009225 | 4 | 0.010 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.010 | |
| foramen ovale closure | GO:0035922 | 1 | 0.010 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.010 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.010 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.010 | |
| oocyte construction | GO:0007308 | 2 | 0.010 | |
| renal system development | GO:0072001 | 225 | 0.010 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.010 | |
| spermatid differentiation | GO:0048515 | 115 | 0.010 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.010 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.010 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.010 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.010 | |
| lung development | GO:0030324 | 164 | 0.010 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.010 | |
| peptide secretion | GO:0002790 | 114 | 0.010 | |
| mitochondrion organization | GO:0007005 | 134 | 0.010 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.010 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.010 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.010 | |
| protein secretion | GO:0009306 | 111 | 0.010 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.010 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.010 | |
